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The safety of injection practices in vaccination programmes
continues to constitute a worldwide concern. According to
studies conducted between 1989 and 1994, unsafe injection
practices are widespread in West and East Africa.1 Although the
550 million injections administered annually in the Expanded
Programme on Immunisation (EPI) in developing countries
comprise only a small fraction of all injections given (Hansen BS,
Phiri ML. Safe injection pactices, taking short cuts in injection
safety costs lives — unpublished paper, 1996), they are also
subject to unsafe practices. According to reports, sterility cannot
be guaranteed in up to one-third of vaccination injections.2
The growing awareness of the dangers of poor sterilisation
and injection technique has motivated several countries to
examine their practices. In the Yamoussoukro Declaration of
1994 African ministers of health pledged to ensure safety, with a
single sterile syringe and needle used for injection throughout
the continent (WHO. Yamoussoukro Declaration on the Safety of
Injections — unpublished document, 1994).
In Swaziland, each child receives 8 injections to complete the
routine vaccination schedule during the first year of life.
Furthermore, as in many other countries, clients seeking
curative care favour injectables over other forms of treatment.
Health workers in Swaziland are taught sterile practices and
injection safety in basic training and during in-service training,
and the EPI guidelines on safe practices have been distributed to
all health facilities. However, unsafe injections continue to occur,
even in settings where health workers have been properly
trained and the policy of one needle and one syringe for each
injection is known. The possible transmission of blood-borne
pathogens such as HIV and hepatitis B through unsafe injections
therefore continues to be a concern. Despite precautions by the
Swaziland Ministry of Health to ensure safe injection practices,
there have been reports of nurses suffering needlestick injuries,
children suffering injection abscesses, and syringes and needles
running out of stock. A health facility survey was conducted to
determine the extent of unsafe injection practices and to identify
mechanisms by which the safety of injections could be assured. 
Methods
A safe injection practice questionnaire was ‘piggybacked’ onto a
health facility study of acute respiratory infection (ARI), and
many of the facilities were selected according to ARI survey
criteria. The sampling frame consisted of those health facilities
that saw 3 or more ARI cases per day during July 1996, the same
month of the previous year of the study. This yielded a total of
27 facilities, all of which were included in the sample. An
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facilities (31%) and syringes and needles were reused at 2
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having pricked their finger in the previous 6 months; in almost
half of these cases this was after administration of an injection.
Seven nurses (25%) recalled seeing a case of an abscess or a
mild adverse event following an injection in the previous 12
months. Interviewers observed used syringes and needles
being placed in a safe container in three-quarters of facilities.
Almost all respondents reported that syringes and needles
were buried or burned.
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routine and supplemental vaccination. The increased cost of
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national Expanded Programme on Immunisation (EPI) budget.
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additional 7 private and company facilities were randomly
selected and added to the list of facilities to provide a nationally
representative sample. Twenty-nine of these 34 facilities
provided injections and were included in the study. Injections
were observed in 26 of these on the day of the visit.
Eleven government and 5 mission clinics, 4 company and 3
private clinics, 2 government hospitals, 2 non-governmental
organisation (NGO) clinics, 1 mission hospital and 1
(government) health centre were  selected. Data were recorded
on a questionnaire adapted from a model data collection tool
(provided by the Co-ordinator of Nursing Affairs,
Commonwealth Regional Health Community Secretariat for
East, Central and Southern Africa, entitled ‘Injection Safety
Rapid Assessment Questionnaire for Health Centres, 2 July
1995’). Interviewers were recruited from their health regions
(equivalent to districts in other countries) and attended a 3-day
training session where the forms were explained, role plays
were enacted and further practice was obtained at the nearest
public health unit where the data collection tool was pre-tested.
Data collection took place on 10 - 17 July 1997. During this
period, a small group of interviewers questioned regional health
management teams (RHMTs) and nursing school principals on
managerial issues related to EPI implementation, using a
structured interview guide. Quantitative data were entered,
cleaned and analysed using EPIINFO version 6.03 software.
Data on disposal of used syringes and needles were collected
both by observation and reported practice. To minimise
potential interviewer and/or respondent bias, all parties were
assured that information gathered would not be used as a basis
for career promotion or for taking disciplinary measures. Free
and informed consent was obtained before data collection.
Codes were used for health facilities and respondents.
Results
Twenty-nine nurses-in-charge were interviewed and injection
technique for EPI vaccinations was observed in the 26 facilities
providing injections on the day of the visit.
When nurses were asked about the number of children they
vaccinated each day, just over half estimated that they gave 2 - 3
intradermal BCG injections per day and 10 - 20 vaccinations per
day for other antigens. The range of estimates for all antigens
per nurse was 0 - 125 injections per day.
Injection technique
A total of 87 injections were directly observed. Not all injections
administered in the health facility could be observed on the day
of the visit because of limited time available. All nurses used
disposable syringes and needles. All injections observed were
administered using the correct dosage, at the correct site and
with the correct equipment. However, as summarised in Fig. 1,
needles were recapped in 8 facilities (31%), changing needles on
the same syringe was observed in 8 facilities (31%), 2 facilities
(8%) re-used disposable syringes and needles, and syringes were
not taken from a sterile pack in 2 facilities (8%). These practices
were observed in most categories of health facility, and in all
regions.
Eight nurses (28%) reported having pricked their finger in
the last 6 months. Four of these pricks occurred before the
injection and 3 after the injection, while the timing of 1 was not
recorded in relation to injecting the client. All nurses who
pricked their finger before giving the injection reported
discarding the needle. There were no reports of needlestick
injury in those facilities that were observed to re-cap needles.
Seven nurses (25%) recalled seeing a case of an abscess or
adverse event following an injection in the previous year.
The reasons given for changing needles on the same syringe
and re-use of syringes and needles were fear of stock running
out, high cost of syringes and needles, and that it was an existing
practice in the facility that the nurse did not feel able to change.
Supply of syringes and needles
Twenty-five facilities (93%) had sufficient stock of syringes and
needles for at least 2 weeks. In all except 2 facilities, the number
of needles in stock was inconsistent with the number of
syringes. In some facilities the stock of needles exceeded that of
syringes. In other facilities the reverse was true. In certain cases
the stock discrepancy reached as much as a 10-fold difference.
Seven respondents (24%) had run out of syringes and needles in
the previous 6 months. Four stock-outs were due to insufficient
delivery. Other reasons were not recorded.
In 3 cases, routine services were suspended, in 2 of these
cases for a period of 7 - 14 days. When asked what action was
taken, 2 nurses said that they referred clients and 1 nurse
reported using insulin syringes instead. Further probing on the
extent of use of insulin syringes was not done.
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Fig. 1. Injection technique, Swaziland 1997.
196
March 2004, Vol. 94, No. 3  SAMJ
ORIGINAL ARTICLES
Disposal of contaminated syringes and needles
Fig. 2 illustrates the reported disposal of used syringes and
needles. Just over half of the nurses reported putting used
syringes and needles in a sealed box or a 2.5 litre medicine
container. WHO/UNICEF-recommended safety boxes were
used in only 3 facilities. In 1 facility the WHO/UNICEF box was
reportedly emptied and re-used. Twenty-four per cent of nurses
reported using an unacceptable method of disposal.
When observing practices, the criteria for safe disposal were
defined as: (i) used injection equipment not put in a receiver (e.g.
kidney basin); (ii) needle not recapped; and (iii) syringe and
needle either placed in a puncture-proof sealed box or disposed
of by means of a needle cutter immediately after use. Based on
observation, 77% of facilities placed used syringes and needles
in a safe container, corresponding exactly with reported practice.
Health facilities where unsafe practices occurred were primarily
government, mission and NGO clinics.
Once placed in a container, 70% of nurses reported burning
or incinerating used syringes and needles. The remaining 30%
buried them or put them in a pit latrine. Disposal sites were not
visited to determine if there was any residual risk to the
community from incomplete destruction. 
Mechanisms to support safety of injection practices
All RHMTs reported disseminating national EPI policy
guidelines on injection safety to all facilities and training health
workers on that policy. All RHMTs reported providing a budget
for injection equipment, with clinic supervisors providing these
supplies to health facilities on a regular basis. However, because
of lack of transport, supervisors in some regions reported being
unable to visit facilities for several months at a time. Interviews
with staff at central level revealed that there was limited input
from technical staff or from RHMTs regarding decisions on
vehicle allocation to regions.
Contrary to RHMT perceptions, only 38% of nurses
interviewed reported having a copy of the national EPI policy
guidelines in their facility. Seventy-nine per cent of nurses
reported that their staff had received basic training in EPI and
82% had received in-service training. All had received basic
training in sterile practices and vaccine handling, and 60% had
also received this training in-service. A total of 42% of nurses
had received in-service training within the last month.
Fifty per cent of nurses had received a supervisory visit
within the last 3 months, but 30% last saw their supervisor 10 or
more months ago. During the last supervisory visit, 42% of
nurses reported receiving adequate supervision on injection
technique and said that syringe stocks and collection for
disposal practices were checked. The only instance where
supervision was associated with better practice was on re-
capping needles (p < 0.05). Otherwise there was no association
between frequency of in-service training and the
implementation of injection safety practices.
Discussion
Health facilities in Swaziland use disposable syringes and
needles because they are cheap and acceptable to the public. Of
all the types of injection equipment available, they carry the
highest risk to patients, health care workers and the community
combined if they are reused, recapped or incorrectly disposed
of.3 Adherence to safe injection practices is therefore critical.
The observed dosage, site of injection and injection
equipment used were correct in all health facilities, which is
highly commendable. However, the findings of the present
study clearly indicate that the client is particularly exposed to
unacceptable risks from re-use of syringes and needles.
Although community risk was not investigated directly, upon
feedback of the study results to health workers in Swaziland
there was general consensus that the community is also exposed
to unacceptable risk from unsafe disposal of injection
equipment. These findings are very disturbing because of the
high prevalence of HIV and hepatitis B in the country. If we
assume that 26% of women who delivered were HIV-positive at
the time of the study4 and 30% infect their newborns, then 7.8%
or 1 in 13 infants presenting to health facilities is HIV-positive.
Most health workers are vaccinating 10 - 20 children per day, so
on average each day they will inject at least 1 HIV-positive child.
This is especially disturbing if unsafe injections are indeed
responsible for a greater proportion of HIV infection than
previously thought.5
Disposable syringes and needles also carry risk to the health
provider through recapping and inadequate disposal.
Surprisingly, those who reported experiencing a needle prick
were not observed recapping needles, although recall over a 6-
month period may not be reliable and is a limitation for this
indicator. One study6 has reported that for every 500 injections
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Fig. 2. Collection for disposal of syringes and needles, Swaziland
1997.
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given, 1 health worker suffers a needlestick injury. The present
study did not measure a comparable indicator, but 28% of
respondents reported having pricked their finger in the previous
6 months and half of the fingerpricks took place after an
injection, suggesting that health workers need to be much more
careful.
Adequate support to ensure safe injections, namely adequate
training, supervision and supplies, is essential to minimise the
risks involved.7 Of great concern is the very limited frequency,
quality and impact of supervision that this study revealed in
Swaziland. That there was considerable difference between
stock levels of syringes and needles supports the observation
that changing needles on the same syringe was common. Studies
elsewhere have also revealed that despite staff training and
knowledge of EPI policy, disposable injection equipment is re-
used.8
Conclusions
There is no longer any justification not to switch to using auto-
disable syringes for all routine and supplemental vaccinations.
While the cost of auto-disable syringes remains marginally
higher than that of disposable syringes and needles, in 1998
disposable syringes and needles represented only 4.7% of the
total cost of the routine vaccine budget in Swaziland. In the same
year, the cost of auto-disable syringes was twice the cost of
disposable syringes and needles. However, by 2002, it was only
30% more. Increasing the investment in injection equipment
therefore represents a small increment when compared with the
total cost of the national EPI programme. In addition to auto-
disable syringes, governments and partner agencies should
ensure that EPI budgets include the cost of sufficient disposal
boxes for all used syringes and needles.
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